Literature DB >> 23706097

Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling.

Florian Veit1, Oleg Pak, Bakytbek Egemnazarov, Markus Roth, Djuro Kosanovic, Michael Seimetz, Natascha Sommer, Hossein A Ghofrani, Werner Seeger, Friedrich Grimminger, Ralf P Brandes, Ralph T Schermuly, Norbert Weissmann.   

Abstract

AIMS: Chronic hypoxia induces pulmonary hypertension (PH) that is concomitant with pulmonary vascular remodeling. Reactive oxygen species (ROS) are thought to play a major role in this. Recent findings suggest that ROS production by NADPH oxidase 4 (Nox4) is important in this remodeling. We investigated whether ROS production by Nox is also important in an inflammatory model of monocrotaline (MCT)-induced PH. We examined ROS production, their possible sources, and their impact on the function of pulmonary arterial smooth muscle cells (PASMC) isolated from MCT-treated and healthy rats.
RESULTS: MCT-PASMC showed increased intracellular superoxide production, migration, and proliferation compared with healthy controls due to increased Nox1 expression. A comparison of PASMC from MCT- and nontreated rats revealed an up-regulation of Sod2, Nrf2, cyclin D1, and matrix metalloproteinase-9 (MMP-9) as well as an increased phosphorylation of cofilin and extracellular signal-regulated kinases (Erk). Expression of Sod2, Nrf2, and cyclin D1 and phosphorylation of cofilin and Erk were Nox1 dependent. INNOVATION: The role of ROS in PH is not fully understood. Mitochondria and Nox have been suggested as sources of altered ROS generation in PH, yet it remains unclear whether increased or decreased ROS contributes to the development of PH. Our studies provide evidence that for different triggers of PH, different Nox isoforms regulate proliferation and migration of PASMC.
CONCLUSION: In contrast to hypoxia-induced PH, Nox1 but not Nox4 is responsible for pathophysiological proliferation and migration of PASMC in an inflammatory model of MCT-induced PH via increased superoxide production. Thus, different Nox isoforms may be targeted in different forms of PH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23706097     DOI: 10.1089/ars.2012.4904

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  30 in total

Review 1.  NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.

Authors:  Jing-Jie Peng; Bin Liu; Jin-Yun Xu; Jun Peng; Xiu-Ju Luo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-11       Impact factor: 3.000

2.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

Review 3.  Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia.

Authors:  Larissa A Shimoda
Journal:  Physiology (Bethesda)       Date:  2020-07-01

4.  NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertension.

Authors:  C Veith; S Kraut; J Wilhelm; N Sommer; K Quanz; W Seeger; R P Brandes; N Weissmann; K Schröder
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 5.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 6.  Hypoxia-inducible factor signaling in pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Argen Mamazhakypov; Norbert Weissmann; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

7.  Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.

Authors:  Zdravka Daneva; Victor E Laubach; Swapnil K Sonkusare
Journal:  Curr Opin Physiol       Date:  2019-05-09

Review 8.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

Review 9.  Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension.

Authors:  Christine Veith; Ralph T Schermuly; Ralf P Brandes; Norbert Weissmann
Journal:  J Physiol       Date:  2015-09-30       Impact factor: 5.182

10.  Beneficial effects of fenofibrate in pulmonary hypertension in rats.

Authors:  Palak Galhotra; Pankaj Prabhakar; Himanshu Meghwani; Soheb A Mohammed; Sanjay Kumar Banerjee; Sandeep Seth; Milind P Hote; K H Reeta; Ruma Ray; Subir Kumar Maulik
Journal:  Mol Cell Biochem       Date:  2018-05-14       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.